UNSPSC 51201569: Atlizumab or tocilizumab

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51201569

Definition

This classification denotes a monoclonal antibody with the molecular formula C6428H9976N1720O2018S42, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier I031V2H011, more generally known as tocilizumab. European Medicines Agency schedules tocilizumab in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB20313. The term TOCILIZUMAB is an International Non-Proprietary Name or INN. see WHO INN reference publication, Volume 18, no. 3, 2004, list 52.

Atlizumab or tocilizumab bears US NLM identifiers UMLS ID C1609165 and NCI Concept Code C84217.

About UNSPSC 51201569

UNSPSC 51201569 Atlizumab or tocilizumab is a Commodity code that nominally describes pharmaceutical products used to treat rheumatoid arthritis, giant cell arteritis, and related inflammatory conditions. Recent state and local contract opportunities posted under this code show a sharp mismatch: the three opportunities in the dataset are for a District Attorney's Office Dog (Washington County, Oregon), athletic training services for fire and police departments (City of Tucson), and medical aid supplies including first aid kits and bandages (City of Tampa). None involve atlizumab or tocilizumab procurement. The code shows little relevant recent activity for pharmaceutical acquisition by state and local buyers.

The geographic spread of the three opportunities spans Oregon, Arizona, and Florida, but they do not represent a coherent procurement pattern under this code's stated scope. The athletic training services RFP (City of Tucson, due June 9, 2026) and medical aid supplies ITB (City of Tampa, due April 9, 2025) are both health-related, but neither targets the biologic immunosuppressant drugs the code nominally covers. The mismatch suggests either a data-entry error in the coding of these opportunities or a significant divergence between the UNSPSC taxonomy label and how state and local procurement offices are using the code in practice. Business development professionals should verify category coding with target agencies before pursuing opportunities tagged to this code.

Quick answers

What is UNSPSC 51201569?

UNSPSC 51201569 is Atlizumab or tocilizumab, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51201569?

UNSPSC 51201569 maps to 1 NIGP code, 26987 Therapeutic Agents, Unclassified.

On GovTribe

See everything under UNSPSC 51201569

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code